About AHABIR
"AHABIR" belongs to Anti Neoplastics therapy of Oncology Division and it is available in 2 forms : Ahabir 250Mg Tablet and Ahabir 500 Mg Tablets.
(Read More)
Ahabir brand of Abiraterone in combination with ADT became first hormonal therapy to receive approval in mCRPC & mCSPC. Ahabir Medicines significantly extended the survival of prostate cancer patients with a good quality of life. Ahabir belongs to Anti Neoplastic therapy of Oncology Division and it is available in 1 form: Ahabir 250Mg Tablet.
